Open Access Open Access  Restricted Access Subscription or Fee Access

Assessment of Knowledge, Attitude and Practice of Pharmacovigilance and Adverse Drug Reaction Reporting Among Nursing Staff

Mahnoor Muskaan, Iqbal Unnisa, Md Samiya, Shiv Kumar Shette


WHO characterizes adverse drug reaction (ADR) as any reaction to a medication which is harmful and unintended, and which happens at measurements typically utilized as a part of man for prophylaxis, analysis or treatment of illness or for the alteration of physiological capacity. The review reveals that nursing staffs have unfortunate information and unfortunate practice yet great in disposition towards ADR announcing. Despite the fact that they have revealed a more noteworthy number of extreme ADRs, they played out no further intercessions to forestall it. The main consideration which deters them from announcing ADR is a patient privacy issue and it was more essential to oversee patient. Reality of response, bizarreness of response, contribution of new medication, trust in analysis of ADR was the variables that urge nursing staffs to report ADR. In light of the results of the current review following suggestions are finished up. ADR revealing structures ought to be uninhibitedly accessible in all clinics as it can further develop the detailing paces of ADR in the country. ADR detailing ought to be obligatory for all medical services experts. Every medical clinic ought to have an information base on ADR which ought to be considered by medical services experts. The nursing schedule educational program should be changed to incorporate ADR and pharmacovigilance. Constant instruction program and studio need to be directed routinely connect with how and where to report ADR.


PV, ADR, Nursing staff, WHO, polypharmacy.

Full Text:



WHO, International drug monitoring: the role of national centres, Report of a WHO meeting. Technical Report Series .1971.

A. F. Macedo, C. Alves, N. Craveiro, et.el,, “Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions, Journal of nursing management.2011;19(3):395-399.

E. C. Davies, C. F. Green, D. R. Mottram, et.el,,Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admission. British journal of clinical pharmacology.2010;70(5):749-755.

C. Giardina, P. M. Cutroneo, E. Mocciaro et al., “Adverse drug reactions in hospitalized patients: results of the FORWARD (facilitation of reporting in hospital ward) study. Frontiers in pharmacology.2018;9:350.

G. Baker, P. Norton, V. Flintoft et al., “The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. Canadian Medical Association Journal.2004;170(11):1678-1686.

C. Kongkaew, P. R. Noyce, and D. M. Ashcroft, “Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies,” Annals of Pharmacotherapy.2008;42(7-8):1017-1025.

L. M. Khan, “Comparative epidemiology of hospital-acquired adverse drug reactions in adults and children and their impact on cost and hospital stay–a systematic review. European journal of clinical pharmacology.2013;69(12):1985-86.

M. A. Hadi, C. F. Neoh, et.el, “Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting.Integrated pharmacy research & practice.2017;6:91-98.

M. D. Rawlins, “Pharmacovigilance: paradise lost, regained or postponed?: the William withering lecture. Journal of the Royal College of Physicians of London. 1995; 29(1):41.

M. Suyagh, D. Farah, and R. A. Farha, “Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process. Saudi Pharmaceutical Journal.2015; 23(2):147-153.

J. Lexchin, “Is there still a role for spontaneous reporting of adverse drug reactions?. Canadian Medical Association Journal.2006;174(2):191-2 .

J. Sultana, P. Cutroneo, and G. Trifirò, “Clinical and economic burden of adverse drug reactions. Journal of pharmacology & pharmacotherapeutics.2013;4(1_suppl):s-73-7.

T. T. le, T. T. H. Nguyen, C. Nguyen et al., “Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. Journal of Clinical Pharmacy and Therapeutics.2020;45(1):122-7.

A. De Angelis, A. Giusti, S. Colaceci, et.el, Nurses' reporting of suspect adverse drug reactions: a mixed-methods study. Annali dell'Istituto superiore di sanita. 2015;51(14):277-83.

H. H. Ampadu, J. Hoekman, M. L. de Bruin et al., Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase. Drug Safety.2016; 39(4): 335-45.

A. Zimmermann, A. Flis, A. Gaworska-Krzemińska, and M. N. Cohen, “Drug-safety reporting in Polish nursing practice—cross sectional surveys. Plos one.2020;15(10):e0241377.

R. Griffith, Nurses must report adverse drug reactions. British Journal of Nursing.2013;22(8):484-5.

T. Schutte, R. van Eekeren, M. Richir et al., “The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study. Naunyn-Schmiedeberg's archives of pharmacology. 2018; 391(1):17-26.

A. D. Angelis, L. Pancani, P. Steca et al., “Testing an explanatory model of nurses’ intention to report adverse drug reactions in hospital settings. Journal of Nursing Management.2017;25(4):307-17.

N. Haider and F. Mazhar, “Factors associated with underreporting of adverse drug reactions by nurses: a narrative literature review.Saudi Journal for Health Sciences.2017;6(2):71.

A. Conforti, S. Opri, P. D'Incau et al., “Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance database.Pharmacoepidemiology and drug safety.2012;21(6):597-602.

D. Mendes, C. Alves, and M. F. Batel, “Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports. Journal of Nursing Management. 2014;22(3):322-330.


  • There are currently no refbacks.

Copyright (c) 2022 Research & Reviews: A Journal of Pharmacology